Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedJun 30, 2022
DataAggregated Company Financials
  • 7D1.4%
  • 3M4.9%
  • 1Y-3.8%
  • YTD3.0%

The Pharma industry is up 1.4% in the last week, with Daiichi Sankyo Company up 3.8%. In contrast, the industry has lost 3.8% in the last 12 months. Earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 01 Jul 2022JP¥35.7tJP¥13.1tJP¥1.5t18.1x
Sun, 29 May 2022JP¥34.5tJP¥13.1tJP¥1.5t17.8x
Tue, 26 Apr 2022JP¥35.1tJP¥12.8tJP¥1.5t20.6x
Thu, 24 Mar 2022JP¥35.0tJP¥12.8tJP¥1.5t20.7x
Sat, 19 Feb 2022JP¥34.1tJP¥12.8tJP¥1.5t18.4x
Mon, 17 Jan 2022JP¥33.5tJP¥12.5tJP¥1.6t17.4x
Wed, 15 Dec 2021JP¥34.0tJP¥12.5tJP¥1.6t18.3x
Fri, 12 Nov 2021JP¥35.8tJP¥12.5tJP¥1.6t18.2x
Sun, 10 Oct 2021JP¥36.0tJP¥12.2tJP¥1.5t17.9x
Tue, 07 Sep 2021JP¥38.6tJP¥12.3tJP¥1.5t18.4x
Thu, 05 Aug 2021JP¥34.1tJP¥12.3tJP¥1.5t17x
Sun, 09 May 2021JP¥35.1tJP¥11.9tJP¥1.4t18.2x
Wed, 10 Feb 2021JP¥39.2tJP¥12.0tJP¥1.3t22.1x
Tue, 03 Nov 2020JP¥33.1tJP¥12.0tJP¥1.2t22.2x
Fri, 07 Aug 2020JP¥36.9tJP¥12.0tJP¥1.3t22.3x
Thu, 30 Apr 2020JP¥35.1tJP¥12.0tJP¥1.2t21.5x
Sun, 02 Feb 2020JP¥36.6tJP¥11.9tJP¥1.2t21x
Wed, 06 Nov 2019JP¥33.6tJP¥11.5tJP¥1.2t19.9x
Sat, 10 Aug 2019JP¥30.2tJP¥11.0tJP¥1.2t19.5x
Median PE Ratio


Total Market Cap: JP¥29.2tTotal Earnings: JP¥1.2tTotal Revenue: JP¥11.0tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Median PE3Y Average 20.1x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 26.3x.
  • The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 7.7% per year over the last three years.
  • Revenues for these companies have grown 6.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Japanese Pharma compare with similar industries?

JP Market0.26%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4568 Daiichi Sankyo CompanyJP¥3.44k3.8%
4502 Takeda PharmaceuticalJP¥3.82k3.0%
4578 Otsuka HoldingsJP¥4.82k5.8%
4528 Ono PharmaceuticalJP¥3.48k6.6%
4523 EisaiJP¥5.73k2.9%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News